You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Newly Diagnosed ITP

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

ITP - Immune Thrombocytopenia Trial (hetrombopag 5mg po qd, High-dose Dexamethasone)

Not yet recruiting
  • ITP - Immune Thrombocytopenia
  • hetrombopag 5mg po qd
  • High-dose Dexamethasone
  • (no location specified)
Jul 5, 2023

Immune Thrombocytopenia, Purpura, Thrombocytopenic Trial in Jinan (Atorvastatin 20mg, Atorvastatin 10mg, Dexamethasone)

Not yet recruiting
  • Immune Thrombocytopenia
  • Purpura, Thrombocytopenic
  • Atorvastatin 20mg
  • +2 more
  • Jinan, Shandong, China
    Qilu hospital, Shandong University
Aug 30, 2021

Immune Thrombocytopenia (ITP) Trial in Germany (Eltrombopag, Dexamethasone)

Recruiting
  • Immune Thrombocytopenia (ITP)
  • Mannheim, Baden-Wuerttemberg, Germany
  • +24 more
Dec 19, 2022

Primary Immune Thrombocytopenia (ITP) Trial in Switzerland (Eltrombopag (Revolade®), standard therapy (without eltrombopag):

Recruiting
  • Primary Immune Thrombocytopenia (ITP)
  • Eltrombopag (Revolade®)
  • standard therapy (without eltrombopag): HD-DXM
  • Aarau, Switzerland
  • +5 more
Sep 5, 2022

Thrombocytopenia Trial (Chidamide, HD-DXM)

Not yet recruiting
  • Thrombocytopenia
  • (no location specified)
Jun 6, 2022

Primary Immune Thrombocytopenia Trial (2.5mg/d Hetrombopag)

Not yet recruiting
  • Primary Immune Thrombocytopenia
  • 2.5mg/d Hetrombopag
  • (no location specified)
Mar 28, 2022

Immune Thrombocytopenia Trial in United States (Eltrombopag, Steroids, IVIG)

Recruiting
  • Immune Thrombocytopenia
  • Birmingham, Alabama
  • +26 more
Dec 12, 2022

Immune Thrombocytopenia Trial in Beijing (Dexamethasone, Acetylcysteine)

Unknown status
  • Immune Thrombocytopenia
  • Beijing, Beijing, China
    Peking University Insititute of Hematology, Peking University Pe
Apr 28, 2020

Immune Thrombocytopenia Trial in Bristol (Mycophenolate Mofetil, Prednisolone)

Completed
  • Immune Thrombocytopenia
  • Bristol, United Kingdom
    University Hospital Bristol NHS Foundation Trust
Oct 25, 2022

Immune Thrombocytopenia Trial in Beijing (Baricitinib 2 MG, Dexamethasone)

Recruiting
  • Immune Thrombocytopenia
  • Beijing, China
  • +9 more
Jul 11, 2023

Prostate Cancer, Newly-Diagnosed Prostate Cancer Trial ([18F]PSMA-1007)

Not yet recruiting
  • Prostate Cancer
  • Newly-Diagnosed Prostate Cancer
  • (no location specified)
Nov 3, 2023

Newly Diagnosed Peripheral T-cell Lymphoma Trial in Wuhan (Duvelisib, Chidamide)

Recruiting
  • Newly Diagnosed Peripheral T-cell Lymphoma
  • Duvelisib, Chidamide
  • Wuhan, Hubei, China
    Union Hospital, Tongji Medical College, Huazhong University of S
Jul 27, 2023

nk/T-cell Lymphoma, Newly Diagnosed, Advanced Lymphoma Trial in Beijing (XPO1 inhibitor)

Recruiting
  • nk/T-cell Lymphoma
  • +2 more
  • XPO1 inhibitor
  • Beijing, Haidian, China
    ChinaPLAGH
Apr 18, 2023

Type 1 Diabetes, Type 1 Diabetes (Juvenile Onset), Diabetes, Type 1 Trial in Indianapolis (HAMS-AB, Placebo)

Not yet recruiting
  • Type 1 Diabetes
  • +2 more
  • Indianapolis, Indiana
    Indiana School of Medicine
Sep 28, 2023

Feasibility Trial in Glostrup (NISMA)

Completed
  • Feasibility
  • NISMA
  • Glostrup, Region Hovedstaden, Denmark
    Luise Holberg Lindgren
Sep 26, 2023

Oncology, Psychological Distress Trial (mHealth-delivered music breathing therapy, Online educational modules)

Not yet recruiting
  • Oncology
  • Psychological Distress
  • mHealth-delivered music breathing therapy
  • Online educational modules
  • (no location specified)
Sep 19, 2023

Multiple Sclerosis Trial in Istanbul (Structured exercise training)

Not yet recruiting
  • Multiple Sclerosis
  • Structured exercise training
  • Istanbul, Turkey
    Feray Güngör
Jul 16, 2023

Classic Hodgkin Lymphoma Trial (Concurrent penpulimab and AVD, Sequential penpulimab and AVD)

Not yet recruiting
  • Classic Hodgkin Lymphoma
  • Concurrent penpulimab and AVD
  • Sequential penpulimab and AVD
  • (no location specified)
Jul 10, 2023

Acute Myeloid Leukemia in Children Trial (Standard Intervention, Investigational Intervention)

Not yet recruiting
  • Acute Myeloid Leukemia in Children
  • Standard Intervention
  • Investigational Intervention
  • (no location specified)
Aug 8, 2023

HIV, Hiv Trial (Community Antiretroviral Therapy)

Not yet recruiting
  • HIV Infections
  • Hiv
  • Community Antiretroviral Therapy
  • (no location specified)
Nov 6, 2023

Multiple Sclerosis (MS) Trial in Birmingham (Physical activity behavioral intervention in persons newly diagnosed with MS)

Recruiting
  • Multiple Sclerosis (MS)
  • Physical activity behavioral intervention in persons newly diagnosed with MS
  • Birmingham, Alabama
    University of Alabama at Birmingham
Jan 24, 2023

Immune Thrombocytopenia Trial in Beijing (Cyclosporine Oral Product, Prednisone)

Not yet recruiting
  • Immune Thrombocytopenia
  • Beijing, Beijing, China
    Peking University Insititute of Hematology, Peking University Pe
Jul 14, 2022

Newly-diagnosed Ph+ Acute Lymphoblastic Leukemia Trial in Xi'an (Olverembatinib plus venetoclax and dexamethasone)

Recruiting
  • Newly-diagnosed Ph+ Acute Lymphoblastic Leukemia
  • Olverembatinib plus venetoclax and dexamethasone
  • Xi'an, Shannxi, China
    Department of Hematology, Xijing Hospital, Fourth Military Medic
Oct 9, 2023

Glioblastoma Multiforme Trial (WP1066)

Not yet recruiting
  • Glioblastoma Multiforme
  • (no location specified)
May 18, 2023

Newly Diagnosed Peripheral T-cell Lymphoma Trial in Nanjing (CMOP+Chidamide)

Recruiting
  • Newly Diagnosed Peripheral T-cell Lymphoma
  • Nanjing, Jiangsu, China
    Hematological Department, People's Hospital of Jiangsu Province
Jun 1, 2023